All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

U.S. Provides Experimental Ebola Drug for Clinical Trials in Congo Amid Worsening Outbreak

By

Mariam Sunny, Siddhi Mahatole And Jennifer Rigby

15h ago· 5 min readenNews

Summary

The U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for clinical trials to combat the worsening Ebola outbreak in the Democratic Republic of Congo. This marks a shift from the U.S. position of reserving the drug only for Americans. The contribution comes after the U.S. dismantled USAID and cut aid to the region, and the CDC has warned this could become the worst Ebola outbreak.

Source

Twitter / XU.S. Provides Experimental Ebola Drug for Clinical Trials in Congo Amid Worsening Outbreakmdsc.pe

Key quotes

· 3 pulled
The U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for use in clinical trials to fight the widening Ebola outbreak in Democratic Republic of Congo
After dismantling the U.S. Agency for International Development and slashing aid to the region, the U.S. is now making modest contributions to assist
the U.S. Centers for Disease Control and Prevention has said could potentially be the worst Ebola outbreak
Snippet from the RSS feed
The U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for use in clinical trials to fight the widening Ebola outbreak in Democratic...

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.